Quotes 5-day view Real-time Euronext Paris
04/08/2021
04/09/2021
04/12/2021
04/13/2021
04/14/2021
Date
84.71(c)
85.06(c)
84.69(c)
84.07(c)
84.43
Last
1 348 869
1 486 808
1 251 699
2 044 073
322 157
Volume
+0.70%
+0.41%
-0.43%
-0.73%
+0.43%
Change
Sales 2021
36 815 M
44 053 M
44 053 M
Net income 2021
5 852 M
7 003 M
7 003 M
Net Debt 2021
7 064 M
8 453 M
8 453 M
P/E ratio 2021
17,9x
Yield 2021
3,90%
Sales 2022
38 935 M
46 590 M
46 590 M
Net income 2022
6 983 M
8 356 M
8 356 M
Net Debt 2022
3 489 M
4 175 M
4 175 M
P/E ratio 2022
15,0x
Yield 2022
4,13%
Capitalization
105 B
125 B
126 B
EV / Sales 2021
3,04x
EV / Sales 2022
2,79x
Nbr of Employees
99 412
Free-Float
88,7%
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:
- pharmaceutical products (71.2%): prescription drugs in the areas of general medicine (57.3% of net sales; mainly for the treatment of diabetes and cardiovascular diseases) and specialty medicine (42.7%; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune...
Notations Surperformance© of Sanofi
Trading Rating :
Investor Rating :
News in other languages on SANOFI
Analyst Recommendations on SANOFI
SANOFI - 04/12
No turn-around in sight
BUY
As vaccine nationalism deepens, governments pay to bring production home
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SANOFI
Short Term Mid-Term Long Term Trends Bullish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
26
Average target price
100,61 €
Last Close Price
84,07 €
Spread / Highest target
39,2%
Spread / Average Target
19,7%
Spread / Lowest Target
-16,7%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capitalization (M$)
SANOFI 6.82% 125 269